Unknown Manufacturer
CRS-100 is a bacteria-based immune therapy that targets liver metastases. Liver metastases arise from a number of cancers, including colon and pancreas cancers. Despite recent advances, metastasized colorectal and pancreatic cancers remain significant unmet medical needs.
Investigated for use/treatment in cancer/tumors (unspecified) and liver cancer.
